BioCryst Pharmaceuticals Inc (BCRX) earnings · rev $874.8M
These earnings events as JSON? API free 100/dayBioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
This BCRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. Revenue was up 94.1% from 2024-12-31 to 2025-12-31. BCRX currently screens at market cap $1.83B.
When the next BCRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 94.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BCRX research stays on the stock page; the tape stays on the quote page.
BCRX earnings FAQ
What are BCRX's latest revenue and net income?
Latest cached BioCryst Pharmaceuticals Inc (BCRX) revenue for Dec 31, 2025 was $874.8M. Net income was $263.9M. Statements: https://lician.com/financials/bcrx
What is BCRX's latest diluted EPS?
Latest cached BioCryst Pharmaceuticals Inc (BCRX) diluted EPS for Dec 31, 2025 was $1.21.
What period does the latest BCRX earnings print cover?
The latest cached BioCryst Pharmaceuticals Inc (BCRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BCRX revenue change from the prior cached period?
Cached BioCryst Pharmaceuticals Inc (BCRX) revenue was up 94.1% from $450.7M (Dec 31, 2024) to $874.8M (Dec 31, 2025). Statements: https://lician.com/financials/bcrx
Where are BCRX earnings listed?
Cached earnings facts for BioCryst Pharmaceuticals Inc (BCRX) are listed at https://lician.com/earnings/bcrx. Statements: https://lician.com/financials/bcrx
Not investment advice.